您的位置: 首页 > 农业专利 > 详情页

Identification and use of ERK5 inhibitors
专利权人:
Bayer Aktiengesellschaft;Bayer Pharma Aktiengesellschaft
发明人:
NGUYEN, Duy,WORTMANN, Lars,FARIA ALVARES DE LEMOS, Adelaide, Clara,BÖMER, Ulf,SÜLZLE, Detlev,HOLTON, Simon,LECHNER, Christian
申请号:
AU2019232437
公开号:
AU2019232437A1
申请日:
2019.03.01
申请国别(地区):
AU
年份:
2020
代理人:
摘要:
The present invention covers heterocyclic compounds of general formula (I) in which T, U, Y, Z, R1 and R3 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of cancer disorders, as a sole agent or in combination with other active ingredients.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充